~27 spots leftby Apr 2026

Decision Support for Eosinophilic Esophagitis

Recruiting in Palo Alto (17 mi)
JC
Overseen byJoy Chang, MD, MS
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Michigan
No Placebo Group

Trial Summary

What is the purpose of this trial?

The study team is conducting this project to learn more about how patients with eosinophilic esophagitis (EoE) like to use and receive educational materials about treatment options and treatment decision making. This study will assess the efficacy of a decision support intervention to make decisions about treatment and disease management for patients with EoE and will assess the feasibility and acceptability of the intervention to inform future R01-level studies. The study team hypothesize that deploying the intervention will be feasible, and it will demonstrate high acceptability among EoE patients. Additionally, that patients that use the intervention (vs general education about EoE) will report greater treatment knowledge, increased readiness to choose a therapy, adherence to therapy, and follow-up.

Research Team

JC

Joy Chang, MD, MS

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for individuals with Eosinophilic Esophagitis (EoE) or Non-erosive Reflux Disease who are interested in learning about treatment options. Participants should be willing to use educational materials and make decisions regarding their treatment.

Inclusion Criteria

Able to speak and read English
I am over 18 and have an upcoming appointment at UM for EoE.

Exclusion Criteria

Patients that are terminally ill
Patients that do not have an email address or reliable access to the internet
Prisoners and institutionalized individuals due to logistical limitations for use of a web app and follow-up interactions in these populations
See 1 more

Treatment Details

Interventions

  • Patient-Centered Decision Support (Behavioral Intervention)
Trial OverviewThe study compares a decision support tool designed to help patients understand and manage EoE treatments against general education materials. It aims to see if the tool increases knowledge, readiness for therapy choice, adherence, and follow-up.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Decision support tool groupExperimental Treatment1 Intervention
Tailored educational materials
Group II: General education control groupActive Control1 Intervention
General educational materials

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell profile image

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+
Dr. Griffin P. Rodgers profile image

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Executive Officer since 2007

MD, M.A.C.P.

Dr. Griffin P. Rodgers profile image

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Medical Officer since 2007

MD, M.A.C.P.